Hidradenitis Suppurativa Huddle: Better Understand Pathophysiology for a Timely Diagnosis

CE Information

0.75 contact hours

Completion Time

45 minutes

Available Until

May 15, 2026

Posted By

NP Events

Ready to start this activity?

Already registered? Please log in to see your registration information.

Navigate

Overview

Specialties

Adult and Family

Subspecialties

Dermatology and Primary Care

Clinical Topics

Dermatologic Disease and Primary Care

Target Audience

This educational activity is intended for dermatology nurse practitioners and physician associates, as well as those practicing in primary care, who are engaged in the care of patients with hidradenitis suppurativa.

Program Learning Goal

The goal of this educational activity is to improve the knowledge and competence of nurse practitioner and physician associate learners in managing patients with hidradenitis suppurativa.

Learning Objectives

Upon completion of this activity, participants should be able to:

Utilize evidence-based guidelines to diagnose hidradenitis suppurativa in patients presenting with complex or atypical skin lesions
Evaluate clinical data of current and emerging therapeutic options for patients with hidradenitis suppurativa, considering patient-specific factors such as comorbidities and treatment history
Design personalized treatment plans that include patient preferences, lifestyle factors, and shared decision-making to optimize outcomes
Integrate patient perspectives and clinical evidence into collaborative care models that enhance communication and improve adherence to treatment plans

Speakers

Terry Faleye MPAS, PA-C

Dermsurgery Associates – Kingwood
Houston, Texas

Amit Garg MD

Professor & Founding Chair/Department of Dermatology
Zucker School of Medicine at Hofstra/Northwell
Professor/Center for Health Innovations & Outcomes Research
Feinstein Institutes for Medical Research
SVP/Dermatology Service Line
Northwell Health

Martha L. Sikes DMSc, RPh, PA-C

Assistant Professor
Emory University PA Program
Atlanta, Georgia

CE Information

This activity offers 0.75 contact hours to attendees.

Accredited by ANCC.

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (Partners) and the Coalition of Skin Diseases (CSD). Partners for Advancing Clinical Education (Partners) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Disclosures

Partners for Advancing Clinical Education (Partners) requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Partners policies. Others involved in the planning of this activity have no relevant financial relationships.

Primary Author

Terry Faleye, MPAS, PA-C: speaker: AbbVie, Bristol Myers Squibb, Lilly, Regeneron/Sanofi, Sun Pharma, UCB; consultant: Incyte, Pfizer.

Amit Garg, MD: consultant/advisor/speaker: AbbVie, Almirall, Boehringer Ingelheim, Engitix, Immunitas, Incyte, Insmed, Novartis, Pfizer, Sonoma, Sun Pharma, UCB, Union Therapeutics, Zura Bio.

Martha L. Sikes, DMSc, RPh, PA-C: consultant/advisor/speaker: Ortho Dermatologics.

Brindley Brooks: other financial or material support: Incyte, Lilly, Moonlake, Novartis, Sanofi, UCB

Register For This Activity

OnDemand Activity Registration

Select this option to access the activity at no cost

Free

Select

Back to navigate